Early psoriasis and enthesitis response in PsA pts treated with guselkumab predicted longterm clinical response including MDA, DAPSA LDA, DAPSA50, DAPSA remission. Pts w/o early response, only half achieved remission Abs#2115 @RheumNow #ACR22 https://t.co/dnsQcp7cEq